中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Issue 10
Oct.  2016
Turn off MathJax
Article Contents

Related immune manifestations in patients with chronic hepatitis B virus and chronic hepatitis C virus infection

DOI: 10.3969/j.issn.1001-5256.2016.10.009
  • Published Date: 2016-10-20
  • Patients with chronic hepatitis B virus( HBV) and hepatitis C virus( HCV) infection are frequently complicated by autoimmune disorders,which is commonly seen in patients with hepatitis C. This article introduces the mechanism of immune disorders in patients with chronic hepatitis C,the proportion of patients with non-organ specific autoantibody,and the clinical manifestations,diagnosis,and treatment of related immune diseases,such as mixed cryoglobulinemia,glomerulonephritis,Sjogren's syndrome,thyroid disease,and type 2 diabetes,as well as the mechanism of immune disorders,related immune manifestations,and effect of antiviral therapy in patients with chronic hepatitis B. Antiviral therapy for chronic hepatitis B and C can alleviate related immune diseases,but interferon therapy is not appropriate.Therefore,the patients with hepatitis B should be treated with nucleos( t) ide analogues,while those with hepatitis C should be treated with direct-acting antiviral agents.

     

  • loading
  • [1]GILL K,GHAZINIAN H,MANCH R,et al.Hepatitis C virus as a systemic disease:reaching beyond the liver[J].Hepatol Int,2016,10(3):415-423.
    [2]ZIGNEGO AL,GRAGNANI L,PILUSO A,et al.Virus-driven autoimmunity and lymphoproliferation:the example of HCV infection[J].Expert Rev Clin Immunol,2015,11(1):15-31.
    [3]CACOUB P,COMARMOND C,DOMONT F,et al.Cryoglobulinemia vasculitis[J].Am J Med,2015,128(9):950-955.
    [4]MATHEW S,FAHEEM M,IBRAHIM SM,et al.Hepatitis C virus and neurological damage[J].World J Hepatol,2016,8(12):545-556.
    [5]BCKLE BC,SEPP NT.Hepatitis C virus and autoimmunity[J].Auto Immun Highlights,2010,1(1):23-35.
    [6]VERGANI D,MIELI-VERGANI G.Autoimmune manifestation in viral hepatitis[J].Semin Immunopathol,2013,35(1):73-85.
    [7]KEPPEKE GD,CALISE SJ,CHAN EK,et al.Anti-rods/rings autoantibody generation in hepatitis C patients during interferon-α/ribavirin therapy[J].World J Gastroenterol,2016,22(6):1966-1974.
    [8]NARCISO-SCHIAVON JL,SCHIAVON LDE L.Autoantibodies in chronic hepatitis C:a clinical perspective[J].World J Hepatol,2015,7(8):1074-1085.
    [9]WU CH,XU XY,TIAN GS,et al.Serum autoantibodies of patients with chronic hepatitis C and the significance there of in infection of hepatitis C virces[J].Natl Med J China,2006,86(6):390-393.(in Chinese)吴赤红,徐小元,田庚善,等.慢性丙型肝炎患者血清自身抗体检测的研究[J].中华医学杂志,2006,86(6):390-393.
    [10]YANG DH,HO LJ,LAI JH.Useful biomarkers for assessment of hepatitis C virus infection-associated autoimmune disorders[J].World J Gastroenterol,2014,20(11):2962-2970.
    [11]RIGOPOULOU EI,ZACHOU K,GATSELIS N,et al.Autoimmune hepatitis in patients with chronic HBV and HCV infections:patterns of clinical characteristics,disease progression and outcome[J].Ann Hepatol,2013-2014,13(1):127-135.
    [12]SERTI E,CHEPA-LOTREA X,KIM YJ,et al.Successful Interferon-free therapy of chronic hepatitis C virus infection normalizes natural killer cell function[J].Gastroenterology,2015,149(1):190-200.
    [13]SAHEBJAM F,HAJDU CH,NORTEY E,et al.Direct acting antiviral therapy is curative for chronic hepatitis C/autoimmune hepatitis overlap syndrome[J].World J Hepatol,2016,8(14):632-636.
    [14]ANTONELLI A,FERRI C,PAMPANA A,et al.Thyroid disorders in chronic hepatitis C[J].Am J Med,2004,117(1):10-13.
    [15]CACOUB P,COMARMOND C,DOMONT F,et al.Extrahepatic manifestations of chronic hepatitis C virus infection[J].Ther Adv Infect Dis,2016,3(1):3-14.
    [16]YOUNOSSI Z,PARK H,HENY L,et al.Extrahepatic manifestation of hepatitis C:a meta-analysis of prevalence,quality of life,and economic burden[J].Gastroenterology,2016,150(7):1599-1608.
    [17]MAZZARO C,ZORAT F,CAIZZI M,et al.Treatment with peginterferon alfa-2b and ribavirin of hepatitis C virus-associated mixed cryoglobulinemia:a pilot study[J].J Hepatol,2005,42(5):632-638.
    [18]TAMPAKI M,KOSKINAS J.Extrahepatic immune related manifestations in chronic hepatitis C virus infection[J].World J Gastroenterol,2014,20(35):12372-12380.
    [19]LATT N,ALACHKAR N,GURAKAR A.Hepatitis C virus and its renal manifestations:a review and update[J].Gastroenterol Hepatol(N Y),2012,8(7):434-445.
    [20]NAKAJIMA A,ADACHI M,TANAKA M,et al.Membranoproliferative glomerulonephritis and leukocytoclastic vasculitis without cryoglobulin in chronic hepatitis C virus infection[J].Intern Med,2003,42(10):1042-1046.
    [21]UCHIYAMA-TANAKA Y,MORI Y,KISHIMOTO N,et al.Membranous glomerulonephritis associated with hepatitis C virus infection:case report and literature review[J].Clin Nephrol,2004,61(2):144-150.
    [22]EBERT EC.Gastrointestinal and hepatic manifestations of Sjogren syndrome[J].J Clin Gastroenterol,2012,46(1):25-30.
    [23]AKENO N,BLACKARD JT,TOMER Y.HCV E2 protein binds directly to thyroid cells and induces IL-8 production:a new mechanism for HCV induced thyroid autoimmunity[J].J Autoimmun,2008,31(4):339-344.
    [24]STEVEN-HUY B,HAN MD.Extrahepatic manifestation of chronic hepatitis B[J].Clin Liver Dis,2004,8(2):403-418.
    [25]CACOUB P,SAADOUN D,BOURLIERE M,et al.Hepatitis B virus genotypes and extrahepatic manifestations[J].J Hepatol,2005,43(5):764-770.
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Article Metrics

    Article views (2333) PDF downloads(482) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return